Andrea Gallamini Selected Research

Andrea Gallamini Research Topics

Disease

39	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 06/2003
11	Neoplasms (Cancer) 10/2023 - 03/2011
7	Lymphoma (Lymphomas) 08/2019 - 09/2002
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2014 - 09/2002
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2014 - 07/2008
3	Febrile Neutropenia 01/2022 - 01/2018
3	Multiple Myeloma 01/2018 - 06/2005
3	Residual Neoplasm 11/2013 - 08/2007
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019 - 05/2012
2	Pathologic Complete Response 10/2018 - 03/2007
2	Cardiotoxicity 10/2017 - 10/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2015 - 04/2009
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2014 - 01/2006
2	Hematologic Neoplasms (Hematological Malignancy) 05/2013 - 10/2012
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2012 - 10/2007
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Neutropenia 01/2018
1	Hemolysis 12/2017
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 12/2017
1	Anemia 12/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2012
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 05/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2011
1	Leukocytosis (Pleocytosis) 11/2009
1	Hairy Cell Leukemia 11/2009
1	Disease Progression 04/2006
1	Essential Thrombocythemia 03/2005
1	Polycythemia Vera 03/2005

Drug/Important Bio-Agent (IBA)

22	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2007
18	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 08/2007
18	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 08/2007
15	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 08/2007
7	Brentuximab VedotinIBA 01/2022 - 01/2018
6	Vincristine (Oncovin)FDA LinkGeneric 10/2018 - 10/2007
6	Rituximab (Mabthera)FDA Link 11/2013 - 04/2008
5	Prednisone (Sone)FDA LinkGeneric 12/2012 - 10/2007
4	Alemtuzumab (Campath)FDA Link 09/2014 - 01/2006
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2012 - 10/2007
4	Deoxyglucose (2 Deoxy D glucose)IBA 03/2011 - 08/2007
3	Monoclonal AntibodiesIBA 08/2023 - 04/2008
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 01/2018
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2021 - 07/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2012
3	Biomarkers (Surrogate Marker)IBA 10/2016 - 09/2014
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2018
2	PlatinumIBA 08/2019 - 01/2017
2	Etoposide (VP 16)FDA LinkGeneric 10/2011 - 07/2011
2	Procarbazine (Matulane)FDA Link 10/2011 - 07/2011
1	BilirubinIBA 12/2017
1	NivolumabIBA 12/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2017
1	Immunoglobulin G (IgG)IBA 12/2017
1	Immunoglobulins (Immunoglobulin)IBA 03/2016
1	LigandsIBA 03/2016
1	KIR ReceptorsIBA 03/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2015
1	Antineoplastic Agents (Antineoplastics)IBA 09/2014
1	Bendamustine Hydrochloride FDA Link 09/2014
1	Proteins (Proteins, Gene)FDA Link 12/2012
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2012
1	Cladribine FDA LinkGeneric 11/2009
1	Dimethoate (Rogor)IBA 04/2008
1	fludarabineIBA 01/2006
1	Bortezomib (Velcade)FDA Link 06/2005
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2005

Therapy/Procedure

27	Drug Therapy (Chemotherapy) 10/2023 - 09/2002
21	Therapeutics 10/2023 - 06/2003
9	Radiotherapy 10/2023 - 08/2007
3	Transplantation 01/2022 - 12/2008
3	Stem Cell Transplantation 04/2009 - 06/2005
3	Autologous Transplantation 04/2008 - 09/2002
2	Aftercare (After-Treatment) 01/2019 - 09/2014
2	Homologous Transplantation 10/2012 - 03/2007
1	Animal Assisted Therapy 10/2023
1	Treatment Delay 12/2020
1	Drug Tapering 12/2020
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Injections 12/2017
1	Operative Surgical Procedures 07/2016
1	Cranial Irradiation 06/2015
1	Time-to-Treatment 06/2014
1	Intravenous Injections 05/2013
1	Lymphatic Irradiation 10/2012
1	VAP-cyclo protocol 10/2007